JBM (Healthcare) Limited (HKG:2161)

Revenue by Segment

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Branded Medicines	272.23M	190.11M	124.04M	134.33M	134.48M
Branded Medicines Growth	43.20%	53.26%	-7.66%	-0.11%	-5.44%
Health and Wellness Products	104.61M	72.19M	36.52M	38.90M	51.82M
Health and Wellness Products Growth	44.92%	97.67%	-6.13%	-24.93%	-6.32%
Proprietary Chinese Medicines	405.45M	386.12M	359.77M	232.91M	210.85M
Proprietary Chinese Medicines Growth	5.01%	7.33%	54.47%	10.46%	14.59%
Total	782.29M	648.42M	520.32M	406.14M	397.16M
Total Growth	20.65%	24.62%	28.11%	2.26%	4.09%

Revenue by Geography

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Hong Kong	562.01M	462.83M	331.89M	284.61M	300.25M
Hong Kong Growth	21.43%	39.45%	16.61%	-5.21%	5.13%
Mainland China	146.98M	128.43M	135.25M	61.01M	27.81M
Mainland China Growth	14.45%	-5.05%	121.68%	119.39%	18.54%
Macau	38.64M	25.85M	26.42M	35.87M	46.59M
Macau Growth	49.49%	-2.15%	-26.34%	-23.02%	13.95%
Singapore	15.56M	12.51M	9.77M	12.38M	4.88M
Singapore Growth	24.43%	28.04%	-21.09%	153.51%	-60.10%
Others	19.10M	18.80M	17.00M	12.27M	17.62M
Others Growth	1.58%	10.63%	38.50%	-30.37%	-9.01%
Total	782.29M	648.42M	520.32M	406.14M	397.16M
Total Growth	20.65%	24.62%	28.11%	2.26%	4.09%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 22, 2026

Data Sources Report a data error